$227 Million is the total value of DCF Advisers, LLC's 81 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 56.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $14,129,000 | -7.7% | 379,000 | +1.1% | 6.24% | +15.0% |
| MU | Buy | MICRON TECHNOLOGY INC | $12,599,000 | -12.8% | 177,500 | +4.4% | 5.56% | +8.7% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $9,683,000 | +11.9% | 16,000 | +3.2% | 4.27% | +39.4% |
| ABBV | Buy | ABBVIE INC | $8,387,000 | -3.3% | 77,750 | +1.0% | 3.70% | +20.5% |
| ARGX | Buy | ARGENX SEsponsored adr | $7,550,000 | +25.4% | 25,000 | +25.0% | 3.33% | +56.3% |
| XNCR | Buy | XENCOR INC | $7,512,000 | +10.6% | 230,000 | +16.8% | 3.32% | +37.7% |
| SPY | New | SPDR S&P 500 ETF TRcall | $6,652,000 | – | 15,500 | +100.0% | 2.94% | – |
| INCY | Buy | INCYTE CORP | $4,815,000 | -6.2% | 70,000 | +14.8% | 2.12% | +16.9% |
| ALT | Buy | ALTIMMUNE INC | $2,705,000 | +88.4% | 239,200 | +64.1% | 1.19% | +134.6% |
| GLD | Buy | SPDR GOLD TRcall | $2,628,000 | +58.7% | 16,000 | +60.0% | 1.16% | +97.6% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $2,147,000 | -5.3% | 14,500 | +45.0% | 0.95% | +17.9% |
| F | Buy | FORD MTR CO DEL | $1,876,000 | +40.3% | 132,500 | +47.2% | 0.83% | +74.7% |
| IMPL | New | IMPEL NEUROPHARMA INC | $1,827,000 | – | 150,000 | +100.0% | 0.81% | – |
| AAPL | Buy | APPLE INC | $1,769,000 | +158.2% | 12,500 | +150.0% | 0.78% | +221.4% |
| SLV | Buy | ISHARES SILVER TRishares | $1,642,000 | +13.0% | 80,000 | +33.3% | 0.72% | +40.8% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $1,556,000 | +6.4% | 136,501 | +49.5% | 0.69% | +32.6% |
| EQ | Buy | EQUILLIUM INC | $1,266,000 | +177.0% | 185,666 | +139.5% | 0.56% | +245.1% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $1,219,000 | +113.5% | 28,000 | +132.0% | 0.54% | +166.3% |
| BABA | Buy | ALIBABA GROUP HLDG LTDcall | $1,110,000 | -11.0% | 7,500 | +36.4% | 0.49% | +10.9% |
| MRVL | New | MARVELL TECHNOLOGY INC | $1,055,000 | – | 17,500 | +100.0% | 0.47% | – |
| PG | New | PROCTER AND GAMBLE COput | $1,049,000 | – | 7,500 | +100.0% | 0.46% | – |
| LIT | New | GLOBAL X FDSlithium btry etf | $779,000 | – | 9,500 | +100.0% | 0.34% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $765,000 | – | 12,745 | +100.0% | 0.34% | – |
| LLY | New | LILLY ELI & COcall | $578,000 | – | 2,500 | +100.0% | 0.26% | – |
| BIIB | Buy | BIOGEN INC | $566,000 | +63.6% | 2,000 | +100.0% | 0.25% | +103.3% |
| TBT | New | PROSHARES TR | $551,000 | – | 30,000 | +100.0% | 0.24% | – |
| VIAC | Buy | VIACOMCBS INCcl b | $494,000 | +9.3% | 12,500 | +25.0% | 0.22% | +36.2% |
| OVID | Buy | OVID THERAPEUTICS INC | $476,000 | -12.8% | 141,701 | +1.4% | 0.21% | +8.8% |
| MU | Buy | MICRON TECHNOLOGY INCcall | $355,000 | +67.5% | 5,000 | +100.0% | 0.16% | +109.3% |
| INCY | New | INCYTE CORPcall | $344,000 | – | 5,000 | +100.0% | 0.15% | – |
| AIRT | Buy | AIR T INC | $277,000 | +29.4% | 9,671 | +11.5% | 0.12% | +60.5% |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $235,000 | – | 5,000 | +100.0% | 0.10% | – |
| LCTX | Buy | LINEAGE CELL THERAPEUTICS IN | $219,000 | +3.3% | 87,000 | +16.8% | 0.10% | +29.3% |
| ET | New | ENERGY TRANSFER L P | $206,000 | – | 21,500 | +100.0% | 0.09% | – |
| New | VELO3D INC*w exp 12/01/202 | $72,000 | – | 42,000 | +100.0% | 0.03% | – | |
| OCX | New | ONCOCYTE CORP | $43,000 | – | 12,149 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.